Impact Factor 5.511

Among the world's top 10 most-cited Immunology journals

General Commentary ARTICLE

Front. Immunol., 27 November 2013 | https://doi.org/10.3389/fimmu.2013.00414

Erratum: Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis

  • Tytgat Institute for Liver and Intestinal Research, Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, Netherlands

An erratum on

Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis
by Schilderink R, Verseijden C, de Jonge WJ (2013). Front. Immunol. 4:226. doi: 10.3389/fimmu.2013.00226

Figure 1 of Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis has incorrect labels. Attached is an updated and correct version of this figure.

FIGURE 1
www.frontiersin.org

Figure 1. The effects of SCFA-derivative butyrylhydroxamic acid on epithelial cell responses in Caco-2 enterocytes. Cells were left either unstimulated (A) or stimulated with IL1β (10 ng/mL for 24 h); (B), in the presence of indicated butyrylhydroxamic acid concentrations. Secreted levels of IL-8 and CCL-2 were measured and plotted as percentages to vehicle treated unstimulated cells [veh graph (A)].

Citation: Schilderink R, Verseijden C and de Jonge WJ (2013) Erratum: Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front. Immunol. 4:414. doi: 10.3389/fimmu.2013.00414

Received: 17 September 2013; Accepted: 12 November 2013;
Published online: 27 November 2013.

Edited by:

Eric Cox, Ghent University, Belgium

Copyright: © 2013 Schilderink, Verseijden and de Jonge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: r.schilderink@amc.uva.nl